Mark Thomas Esser - AstraZeneca | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 163 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Frequent host-switch and gene exchange shape the evolution of Staphylococcus aureus ST398

crossref（2024）

引用0浏览0引用

Safety, Efficacy and Pharmacokinetics of AZD7442 (tixagevimab/cilgavimab) for Treatment of Mild-to-Moderate COVID-19: 15-Month Final Analysis of the TACKLE Trial

F. D. Richard Hobbs,Hugh Montgomery,Francisco Padilla,Jesus Abraham Simón-Campos,Douglas Arbetter,Seth Seegobin,Alexandre Kiazand,Katie Streicher,Nuria Martinez-Alier,Taylor S. Cohen,Mark T. Esser

INFECTIOUS DISEASES AND THERAPYno. 3 (2024): 521-533

引用0浏览0WOS引用

AZD3152 Neutralizes SARS-CoV-2 Historical and Contemporary Variants and is Protective in Hamsters and Well Tolerated in Adults

Yingyun Cai,Seme Diallo,Kim Rosenthal,Kuishu Ren,Daniel J. Flores,Andrew Dippel,Vaheh Oganesyan,Nydia van Dyk,Xiaoru Chen, Erin Cantu, Rakesh Choudhary,Michal Sulikowski,Hibret Adissu, Bhavna Chawla,Swagata Kar,Chang Liu,Aiste Dijokaite-Guraliuc,Juthathip Mongkolsapaya,Saravanan Rajan,Yueh-Ming Loo,Rohini Beavon,Chris Webber,Lee-Jah Chang,Steven Thomas,Lindsay Clegg, Huixia Zhang,Gavin R. Screaton, Nora Philbin, Mark Harre, Abdulhafez Selim,Nuria Martinez-Alier,Alison Uriel,Taylor S. Cohen,John L. Perez,Mark T. Esser, Wade Blair,Joseph R. Francica

SCIENCE TRANSLATIONAL MEDICINEno. 753 (2024)

引用0浏览0WOSSCIENCE引用

Antibody Targeting of Conserved Sites of Vulnerability on the SARS-CoV-2 Spike Receptor-Binding Domain

STRUCTUREno. 2 (2024)

引用0浏览0WOS引用

Accelerating Therapeutics Development During a Pandemic: Population Pharmacokinetics of the Long-Acting Antibody Combination AZD7442 (tixagevimab/cilgavimab) in the Prophylaxis and Treatment of COVID-19

Lindsay E. Clegg,Oleg Stepanov, Henning Schmidt,Weifeng Tang, Huixia Zhang,Chris Webber,Taylor S. Cohen,Mark T. Esser,Mats Nagard

ANTIMICROBIAL AGENTS AND CHEMOTHERAPYno. 5 (2024)

引用0浏览0WOS引用

In Vivo Expression of an Mrna Encoded Multi-Mechanistic Mab Combination Against Staphylococcus Aureus and Protection in Disease Model

Christine Tkaczyk, Michael Newton, Mun,George Thom,Martin Strain, Adam Gamson,Olalekan Daramola, Andal Murthy,Julie Douthwaite,Oleg Stepanov, Elin Boger, Haitao Yang,Mark T. Esser, Ashley Lidwell,Antonio Digiandomenico,Luis Santos,Bret R. Sellman

Molecular therapy the journal of the American Society of Gene Therapy（2024）

引用0浏览0WOS引用

Serum AZD7442 (Tixagevimab-Cilgavimab) Concentrations and in Vitro IC50 Values Predict SARS-CoV-2 Neutralising Antibody Titres

Lindsay E. Clegg,Oleg Stepanov,Sam Matthews, Tom White,Seth Seegobin,Steven Thomas,Kevin M. Tuffy,Mats Nagard,Mark T. Esser,Katie Streicher,Taylor S. Cohen,Anastasia A. Aksyuk

Clinical & translational immunologyno. 6 (2024)

引用0浏览0WOS引用

Efficacy, Safety, and Pharmacokinetics of AZD7442 (tixagevimab/cilgavimab) for Prevention of Symptomatic COVID-19: 15-Month Final Analysis of the PROVENT and STORM CHASER Trials

Myron J. Levin,Andrew Ustianowski,Stephane De Wit,Rohini Beavon,Jesse Thissen,Seth Seegobin,Kanika Dey,Karen A. Near,Katie Streicher,Alexandre Kiazand,Mark T. Esser

Infectious Diseases and Therapypp.1-16, (2024)

引用0浏览0WOS引用

Durability of Neutralizing RSV Antibodies Following Nirsevimab Administration and Elicitation of the Natural Immune Response to RSV Infection in Infants

Deidre Wilkins,Yuan,Yue Chang,Anastasia A. Aksyuk,Beatriz Seoane Núñez,Ulrika Wählby-Hamrén,Tianhui Zhang,Michael E. Abram,Amanda Leach,Tonya Villafana,Mark T. Esser

Nature Medicineno. 5 (2023): 1172-1179

引用6浏览0WOSNATURE引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn